Becker's Healthcare June 6, 2024
Beginning June 18, a newly finalized rule from the Health Resources and Services Administration will take effect and change how the resolution of disputes within the 340B program is handled.
HRSA experts from the agency’s Office of Pharmacy Affairs will oversee and handle disputes and claims related to overcharges for drugs, diversions of 340B drugs to ineligible patients, and duplicate discounts.
Unlike the previous rule, the new 340B drug pricing program’s administrative dispute resolution process has no minimum claim threshold; aims to streamline procedural processes and remove cumbersome, high-cost legal representation; and allows for an additional review process if either party is unhappy with the resolution.
However, before engaging in the administrative dispute resolution process, both parties must...
Today's Sponsors
Today's Sponsor